USP revises heparin labelling guide

- Last updated on GMT

USP revises Heparin labelling rules
USP revises Heparin labelling rules

Related tags: Health care

The US Pharmacopeial Convention (USP) has changed its labelling rules for heparin in a mid to reduce the number of medication errors.

The standards organisation is revising its monographs for Heparin Sodium Injection and Heparin Lock Flush Solution monographs to ensure that labels list the strength per total volume as well as strength per ml. 

The USP’s concern is that some containers that only show mg per ml information can be misunderstood by healthcare practitioners, creating risk of potential dangerous overdose.

Roger Williams, USP’s CEO, said: “It is our goal to ensure that USP standards aid practitioners in their delivery of quality care to patients. Particularly in light of the public health emergency involving adulterated heparin in 2008, USP and FDA are continuing to work closely together to help ensure that heparin delivery is as safe and accurate as possible​.”

The changes become official on May 1, 2013. 

Related topics: Markets & Regulations, Regulations

Related news

Show more

Related products

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Related suppliers

Follow us

Products

View more

Webinars